Intensity Short Term Investments vs Total Current Assets Analysis

INTS Stock   2.23  0.02  0.90%   
Intensity Therapeutics, financial indicator trend analysis is infinitely more than just investigating Intensity Therapeutics, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Intensity Therapeutics, is a good investment. Please check the relationship between Intensity Therapeutics, Short Term Investments and its Total Current Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intensity Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Short Term Investments vs Total Current Assets

JavaScript chart by amCharts 3.21.1520162018202020222024500K1M1.5M2M2.5M3M3.5M4M4.5M5M5.5M6M6.5M7M7.5M 2M4M6M8M10M12M14M16M18M
JavaScript chart by amCharts 3.21.15Short Term Investmentstotal: 48.3MTotal Current Assetstotal: 119.6M

Short Term Investments vs Total Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Intensity Therapeutics, Short Term Investments account and Total Current Assets. At this time, the significance of the direction appears to have strong relationship.
Short Term InvestmentsTotal Current AssetsDiversified AwayShort Term InvestmentsTotal Current AssetsDiversified Away100%
The correlation between Intensity Therapeutics,'s Short Term Investments and Total Current Assets is 0.79. Overlapping area represents the amount of variation of Short Term Investments that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Intensity Therapeutics, Common, assuming nothing else is changed. The correlation between historical values of Intensity Therapeutics,'s Short Term Investments and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Investments of Intensity Therapeutics, Common are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Short Term Investments i.e., Intensity Therapeutics,'s Short Term Investments and Total Current Assets go up and down completely randomly.

Correlation Coefficient

0.79
Relationship DirectionPositive 
Relationship StrengthSignificant

Short Term Investments

Short Term Investments is an item under the current assets section of Intensity Therapeutics, balance sheet. It contains any investments Intensity Therapeutics, Common undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Intensity Therapeutics, can easily liquidate in the marketplace.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.
Most indicators from Intensity Therapeutics,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Intensity Therapeutics, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intensity Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
At this time, Intensity Therapeutics,'s Issuance Of Capital Stock is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 80.6 M in 2025, whereas Selling General Administrative is likely to drop slightly above 2.3 M in 2025.
 2022 2023 2024 2025 (projected)
Interest Expense81.8K305K350.8K368.3K
Depreciation And Amortization179.0K147K132.3K153.8K

Intensity Therapeutics, fundamental ratios Correlations

-0.57-0.040.141.0-0.76-0.3-0.28-0.9-0.610.90.750.90.880.341.00.41-0.880.77-0.9-0.27-0.440.890.9-0.990.99
-0.570.820.72-0.590.15-0.54-0.170.67-0.28-0.18-0.38-0.18-0.120.44-0.640.390.2-0.710.2-0.18-0.46-0.14-0.330.59-0.49
-0.040.820.92-0.08-0.35-0.83-0.20.15-0.710.330.090.370.40.82-0.120.78-0.28-0.45-0.31-0.21-0.810.410.130.080.04
0.140.720.920.12-0.37-0.93-0.530.08-0.850.540.170.540.590.80.060.79-0.53-0.17-0.53-0.54-0.930.560.39-0.140.25
1.0-0.59-0.080.12-0.71-0.3-0.3-0.89-0.60.90.750.890.870.320.990.38-0.880.79-0.9-0.29-0.430.870.91-1.00.99
-0.760.15-0.35-0.37-0.710.430.270.560.62-0.8-0.38-0.8-0.79-0.39-0.73-0.440.65-0.520.740.270.57-0.78-0.790.7-0.75
-0.3-0.54-0.83-0.93-0.30.430.530.090.91-0.65-0.28-0.67-0.71-0.8-0.22-0.760.650.030.660.530.98-0.67-0.530.32-0.41
-0.28-0.17-0.2-0.53-0.30.270.53-0.140.48-0.540.14-0.42-0.5-0.06-0.24-0.090.53-0.530.521.00.56-0.35-0.640.35-0.36
-0.90.670.150.08-0.890.560.09-0.140.42-0.68-0.9-0.74-0.68-0.36-0.91-0.420.71-0.540.71-0.150.2-0.76-0.630.87-0.86
-0.61-0.28-0.71-0.85-0.60.620.910.480.42-0.87-0.55-0.88-0.91-0.84-0.54-0.860.85-0.190.880.480.96-0.9-0.730.61-0.69
0.9-0.180.330.540.9-0.8-0.65-0.54-0.68-0.870.640.990.990.570.860.62-0.970.63-0.99-0.53-0.770.970.96-0.90.94
0.75-0.380.090.170.75-0.38-0.280.14-0.9-0.550.640.720.660.640.740.68-0.740.25-0.680.15-0.360.760.5-0.720.75
0.9-0.180.370.540.89-0.8-0.67-0.42-0.74-0.880.990.720.990.650.860.7-0.960.55-0.99-0.41-0.780.990.92-0.890.94
0.88-0.120.40.590.87-0.79-0.71-0.5-0.68-0.910.990.660.990.640.830.68-0.970.55-0.99-0.5-0.820.980.93-0.870.92
0.340.440.820.80.32-0.39-0.8-0.06-0.36-0.840.570.640.650.640.270.99-0.61-0.27-0.59-0.06-0.810.710.33-0.30.41
1.0-0.64-0.120.060.99-0.73-0.22-0.24-0.91-0.540.860.740.860.830.270.34-0.840.79-0.86-0.23-0.360.850.88-0.990.98
0.410.390.780.790.38-0.44-0.76-0.09-0.42-0.860.620.680.70.680.990.34-0.66-0.19-0.64-0.09-0.80.750.38-0.360.47
-0.880.2-0.28-0.53-0.880.650.650.530.710.85-0.97-0.74-0.96-0.97-0.61-0.84-0.66-0.590.980.520.75-0.95-0.910.89-0.93
0.77-0.71-0.45-0.170.79-0.520.03-0.53-0.54-0.190.630.250.550.55-0.270.79-0.19-0.59-0.61-0.53-0.090.470.81-0.80.75
-0.90.2-0.31-0.53-0.90.740.660.520.710.88-0.99-0.68-0.99-0.99-0.59-0.86-0.640.98-0.610.510.77-0.97-0.940.91-0.95
-0.27-0.18-0.21-0.54-0.290.270.531.0-0.150.48-0.530.15-0.41-0.5-0.06-0.23-0.090.52-0.530.510.56-0.34-0.630.34-0.35
-0.44-0.46-0.81-0.93-0.430.570.980.560.20.96-0.77-0.36-0.78-0.82-0.81-0.36-0.80.75-0.090.770.56-0.78-0.650.44-0.54
0.89-0.140.410.560.87-0.78-0.67-0.35-0.76-0.90.970.760.990.980.710.850.75-0.950.47-0.97-0.34-0.780.87-0.870.92
0.9-0.330.130.390.91-0.79-0.53-0.64-0.63-0.730.960.50.920.930.330.880.38-0.910.81-0.94-0.63-0.650.87-0.920.93
-0.990.590.08-0.14-1.00.70.320.350.870.61-0.9-0.72-0.89-0.87-0.3-0.99-0.360.89-0.80.910.340.44-0.87-0.92-0.99
0.99-0.490.040.250.99-0.75-0.41-0.36-0.86-0.690.940.750.940.920.410.980.47-0.930.75-0.95-0.35-0.540.920.93-0.99
Click cells to compare fundamentals

Intensity Therapeutics, Account Relationship Matchups

Intensity Therapeutics, fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets10.1M5.2M1.8M17.3M19.9M20.9M
Short Long Term Debt Total497.5K2.3M4.5M158K181.7K172.6K
Other Current Liab952.0K1.3M1.7M891K1.0M1.2M
Total Current Liabilities1.3M3.7M6.8M4.0M4.6M3.7M
Total Stockholder Equity(1.6M)(8.7M)(15.1M)13.2M15.1M15.9M
Property Plant And Equipment Net490.2K318.1K139.1K147K132.3K215.5K
Net Debt(8.8M)(2.2M)3.2M(8.4M)(9.7M)(9.2M)
Retained Earnings(23.2M)(31.1M)(38.7M)(50.5M)(45.5M)(47.7M)
Accounts Payable222.7K172.5K603K3.0M3.5M3.7M
Cash9.3M4.5M1.3M8.6M9.8M6.1M
Non Current Assets Total521.9K485.9K306.8K1.8M2.1M2.2M
Cash And Short Term Investments9.3M4.5M1.3M14.8M17.0M17.8M
Liabilities And Stockholders Equity10.1M5.2M1.8M17.3M19.9M20.9M
Non Current Liabilities Total10.4M10.2M10.0M174K156.6K148.8K
Capital Lease Obligations497.5K325.9K143.2K158K142.2K221.6K
Other Current Assets244.1K139.7K76.2K688K791.2K830.8K
Other Stockholder Equity11.6M22.4M23.6M63.7M73.2M76.9M
Total Liab11.7M13.9M16.9M4.1M3.7M3.5M
Net Invested Capital(1.6M)(6.7M)(10.7M)13.2M15.1M15.9M
Property Plant And Equipment Gross490.2K318.1K139.1K147K132.3K215.5K
Total Current Assets9.6M4.7M1.5M15.5M17.8M18.7M
Net Working Capital8.3M1.0M(5.4M)11.5M10.4M10.9M
Short Term Debt171.2K2.2M4.5M20K23K21.9K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Intensity Stock Analysis

When running Intensity Therapeutics,'s price analysis, check to measure Intensity Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intensity Therapeutics, is operating at the current time. Most of Intensity Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Intensity Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intensity Therapeutics,'s price. Additionally, you may evaluate how the addition of Intensity Therapeutics, to your portfolios can decrease your overall portfolio volatility.